Preface of the Special Issue “Pharmaceutical Crystals”
References
- Ren, Y.; Shen, J.; Yu, K.; Phan, C.U.; Chen, G.; Liu, J.; Hu, X.; Feng, J. Impact of Crystal Habit on Solubility of Ticagrelor. Crystals 2019, 9, 556. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y.; Yang, Z.; Zhang, S.; Zhou, X. Synthesis, Crystal Structure, and Solubility Analysis of a Famotidine Cocrystal. Crystals 2019, 9, 360. [Google Scholar] [CrossRef] [Green Version]
- Yutani, R.; Haku, R.; Teraoka, R.; Tode, C.; Koide, T.; Kitagawa, S.; Sakane, T.; Fukami, T. Comparative Evaluation of the Photostability of Carbamazepine Polymorphs and Co-crystals. Crystals 2019, 9, 553. [Google Scholar] [CrossRef] [Green Version]
- Khan, E.; Shukla, A.; Srivastava, K.; Gangopadhyay, D.; Assi, K.H.; Tandon, P.; Vangala, V.R. Structural and Reactivity Analyses of Nitrofurantoin–4-dimethylaminopyridine Salt Using Spectroscopic and Density Functional Theory Calculations. Crystals 2019, 9, 413. [Google Scholar] [CrossRef] [Green Version]
- Mizoguchi, R.; Uekusa, H. Elucidation of the Crystal Structures and Dehydration Behaviors of Ondansetron Salts. Crystals 2019, 9, 180. [Google Scholar] [CrossRef] [Green Version]
- Du, D.; Ren, G.-B.; Qi, M.-H.; Li, Z.; Xu, X.-Y. Solvent-Mediated Polymorphic Transformation of Famoxadone from Form II to Form I in Several Mixed Solvent Systems. Crystals 2019, 9, 161. [Google Scholar] [CrossRef] [Green Version]
- Huang, Y.; Zhou, L.; Yang, W.; Li, Y.; Yang, Y.; Zhang, Z.; Wang, C.; Zhang, X.; Yin, Q. Preparation of Theophylline-Benzoic Acid Cocrystal and On-Line Monitoring of Co-crystallization Process in Solution by Raman Spectroscopy. Crystals 2019, 9, 329. [Google Scholar] [CrossRef] [Green Version]
- An, H.; Choi, I.; Kim, I.W. Melting Diagrams of Adefovir Dipivoxil and Dicarboxylic Acids: An Approach to Assess Co-crystal Compositions. Crystals 2019, 9, 70. [Google Scholar] [CrossRef] [Green Version]
- Ivashchenko, A.V.; Mitkin, O.D.; Kravchenko, D.V.; Kuznetsova, I.V.; Kovalenko, S.M.; Bunyatyan, N.D.; Langer, T. Synthesis, X-Ray Crystal Structure, Hirshfeld Surface Analysis, and Molecular Docking Study of Novel Hepatitis B (HBV) Inhibitor: 8-Fluoro-5-(4-fluorobenzyl)-3-(2-methoxybenzyl)-3,5-dihydro-4H-pyrimido[5,4-b]indol-4-one. Crystals 2019, 9, 379. [Google Scholar] [CrossRef] [Green Version]
- Al-Wabli, R.I.; Al-Ghamdi, A.R.; Aswathy, S.A.V.; Ghabbour, H.A.; Al-Agamy, M.H.; Hubert Joe, I.; Attia, M.I. (2E)-2-[1-(1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazine carboxamide: Synthesis, X-ray Structure, Hirshfeld Surface Analysis, DFT Calculations, Molecular Docking and Antifungal Profile. Crystals 2019, 9, 82. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yonemochi, E.; Uekusa, H. Preface of the Special Issue “Pharmaceutical Crystals”. Crystals 2020, 10, 89. https://doi.org/10.3390/cryst10020089
Yonemochi E, Uekusa H. Preface of the Special Issue “Pharmaceutical Crystals”. Crystals. 2020; 10(2):89. https://doi.org/10.3390/cryst10020089
Chicago/Turabian StyleYonemochi, Etsuo, and Hidehiro Uekusa. 2020. "Preface of the Special Issue “Pharmaceutical Crystals”" Crystals 10, no. 2: 89. https://doi.org/10.3390/cryst10020089
APA StyleYonemochi, E., & Uekusa, H. (2020). Preface of the Special Issue “Pharmaceutical Crystals”. Crystals, 10(2), 89. https://doi.org/10.3390/cryst10020089